2.31
price down icon1.28%   -0.03
after-market Handel nachbörslich: 2.33 0.02 +0.87%
loading

Finanzdaten der Xbiotech Inc-Aktie (XBIT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
55.37%
6.047
13.55 - 7.904 14.97
Operating Income/Loss
55.37%
-6.047
-13.55 -8.748 -7.904 -14.97
Nonoperating Income/Loss
94.77%
0.141
2.695 -1.801 2.898 1.935
Income/Loss From Continuing Operations Before Tax
45.59%
-5.906
-10.86 -10.55 -5.006 -13.03
Income Tax Expense/Benefit
251.72%
0.102
0.029 -0.041 0.009 -0.025
Income/Loss From Continuing Operations After Tax
44.80%
-6.008
-10.88 -10.51 -5.015 -13.01
Net Income/Loss
44.80%
-6.008
-10.88 -10.51 -5.015 -13.01
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
30.49
30.49 0.0018 30.47 30.46
Basic Earnings Per Share
44.44%
-0.20
-0.36 -0.34 -0.16 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):